EFFICACY AND SAFETY OF RESMETIROM, A SELECTIVE THYROID HORMONE RECEPTOR-β AGONIST, IN THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): A SYSTEMATIC REVIEW AND META-ANALYSIS

Descargar Publicación
Dos tercios de las muertes relacionadas con un IMC elevado se deben a enfermedades cardiovasculares New concepts in the roles of AMPK in adipocyte stem cell biology